Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV000582384 | SCV000687422 | likely benign | Hereditary cancer-predisposing syndrome | 2017-06-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000613445 | SCV000729561 | likely benign | not specified | 2017-09-26 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001499375 | SCV001704139 | likely benign | Ataxia-telangiectasia syndrome | 2023-11-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000582384 | SCV004849119 | uncertain significance | Hereditary cancer-predisposing syndrome | 2015-04-02 | criteria provided, single submitter | clinical testing | The c.2839-7A>G intronic alteration consists of a A to G substitution 7 nucleotides before coding exon 18 in the ATM gene. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Myriad Genetics, |
RCV004592825 | SCV005082764 | likely benign | Familial cancer of breast | 2024-05-10 | criteria provided, single submitter | clinical testing | This variant is considered likely benign. This variant is intronic and is not expected to impact mRNA splicing. |